HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Ji Selected Research

Tolperisone

1/2020Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].
5/2017The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Ji Research Topics

Disease

27Neoplasms (Cancer)
01/2022 - 03/2006
26Alzheimer Disease (Alzheimer's Disease)
01/2022 - 02/2001
14Inflammation (Inflammations)
05/2022 - 09/2008
13Atherosclerosis
05/2022 - 10/2008
10Hypertension (High Blood Pressure)
01/2022 - 04/2006
10Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2009
10Cognitive Dysfunction
01/2022 - 01/2016
9Hypertrophy
08/2022 - 01/2013
9Dementia (Dementias)
01/2022 - 01/2016
7Cardiomegaly (Heart Hypertrophy)
08/2022 - 02/2005
7Stroke (Strokes)
07/2020 - 11/2014
7Reperfusion Injury
01/2017 - 06/2008
6Fibrosis (Cirrhosis)
03/2022 - 01/2015
6Amyloid Plaque
12/2020 - 06/2008
6Neoplasm Metastasis (Metastasis)
07/2020 - 12/2011
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2017 - 06/2008
6Atherosclerotic Plaque (Atheroma)
12/2016 - 01/2013
5Heart Diseases (Heart Disease)
01/2022 - 07/2003
5Coronary Artery Disease (Coronary Atherosclerosis)
11/2021 - 04/2006
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 07/2008
5Thrombosis (Thrombus)
01/2019 - 04/2004
5Hyperhomocysteinemia
01/2019 - 01/2016
5Ischemia
07/2016 - 06/2008
5Carcinoma (Carcinomatosis)
01/2012 - 04/2004
4Carcinogenesis
01/2022 - 11/2015
4Atrophy
03/2021 - 01/2015
4Ischemic Stroke
01/2021 - 09/2015
4Hemorrhage
12/2020 - 04/2004
4Wounds and Injuries (Trauma)
11/2020 - 12/2012
4Myocardial Infarction
01/2019 - 07/2016
4Necrosis
09/2015 - 01/2008
3Infections
01/2022 - 08/2004
3Lewy Body Disease (Lewy Body Dementia)
01/2022 - 01/2021
3Colonic Neoplasms (Colon Cancer)
12/2021 - 03/2007
3Liver Neoplasms (Liver Cancer)
09/2021 - 04/2004
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2021 - 04/2004
3Chronic Renal Insufficiency
04/2021 - 11/2016
3Liver Diseases (Liver Disease)
04/2021 - 04/2004
3Pain (Aches)
02/2021 - 04/2017
3Heart Failure
01/2021 - 07/2003
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 04/2004
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2021 - 01/2019
3Frontotemporal Dementia (Semantic Dementia)
12/2020 - 01/2013
3Stomach Neoplasms (Stomach Cancer)
01/2019 - 05/2010
3Lung Neoplasms (Lung Cancer)
02/2018 - 05/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2014 - 01/2012
3Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
12/2013 - 10/2010
3Infarction (Infarctions)
12/2013 - 06/2008
3Lymphatic Metastasis
02/2012 - 12/2011

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2005
13Hydrogen Sulfide (Sulfide, Hydrogen)IBA
08/2019 - 06/2008
11Apolipoproteins E (ApoE)IBA
05/2022 - 01/2013
11Glucose (Dextrose)FDA LinkGeneric
12/2020 - 05/2004
8CytokinesIBA
01/2020 - 06/2008
8Messenger RNA (mRNA)IBA
01/2019 - 02/2012
8ApolipoproteinsIBA
12/2017 - 01/2013
7Pharmaceutical PreparationsIBA
01/2021 - 01/2016
7HomocysteineIBA
01/2021 - 01/2015
7Peptides (Polypeptides)IBA
01/2019 - 02/2001
6GYY 4137IBA
01/2021 - 08/2013
5LipidsIBA
05/2022 - 01/2009
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
5CholesterolIBA
01/2022 - 01/2013
5Small Interfering RNA (siRNA)IBA
01/2021 - 01/2018
4oxidized low density lipoproteinIBA
05/2022 - 06/2019
4NucleotidesIBA
01/2022 - 01/2016
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2022 - 01/2010
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 05/2008
4Carrier Proteins (Binding Protein)IBA
01/2022 - 01/2019
4MicroRNAs (MicroRNA)IBA
12/2021 - 05/2010
4Biological ProductsIBA
09/2021 - 10/2010
4Phosphotransferases (Kinase)IBA
01/2021 - 07/2003
4Amyloid (Amyloid Fibrils)IBA
12/2020 - 10/2010
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2019 - 01/2015
4sodium bisulfide (NaHS)IBA
01/2018 - 06/2008
3Angiotensin IIIBA
12/2021 - 01/2013
3RNA (Ribonucleic Acid)IBA
04/2021 - 05/2010
3LigandsIBA
01/2021 - 09/2010
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 12/2015
3Niacin (Nicotinic Acid)FDA LinkGeneric
12/2020 - 01/2017
3Prostaglandin D2IBA
12/2020 - 01/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2020 - 09/2010
3InflammasomesIBA
01/2020 - 01/2016
3EnzymesIBA
02/2017 - 11/2011
3Superoxide DismutaseIBA
01/2017 - 10/2013
3AntioxidantsIBA
01/2017 - 01/2013
3aliskirenFDA Link
01/2017 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2011
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2017 - 06/2008
3Amyloid beta-PeptidesIBA
01/2015 - 02/2001
3Therapeutic UsesIBA
01/2015 - 01/2008
3Peroxidase (Myeloperoxidase)IBA
10/2013 - 06/2008
3Heme Oxygenase-1IBA
05/2009 - 06/2008

Therapy/Procedure

16Therapeutics
01/2022 - 01/2008
6Activities of Daily Living (ADL)
01/2021 - 01/2016
4Lung Transplantation
10/2022 - 01/2021
4Length of Stay
02/2021 - 05/2017
3Drug Therapy (Chemotherapy)
11/2021 - 11/2011
3Artificial Respiration (Mechanical Ventilation)
06/2021 - 01/2012
3Transplantation
12/2016 - 04/2004